BIOL 375 Virology: Difference between revisions
Slonczewski (talk | contribs) |
Slonczewski (talk | contribs) |
||
Line 1: | Line 1: | ||
==BIOL 375 Virology: Term Projects 2010== | ==BIOL 375 Virology: Term Projects 2010== | ||
[[Human Chromosomal Integration of Latent State Human Herpes Virus 6 (HHV-6)]] by Kerri-Lynn Conrad | |||
[[Infection Mechanism of Genus Ebolavirus]] by Keith Miller | [[Infection Mechanism of Genus Ebolavirus]] by Keith Miller | ||
[[Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients]] by Sally Wilson | [[Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients]] by Sally Wilson | ||
Revision as of 01:40, 6 November 2010
BIOL 375 Virology: Term Projects 2010
Human Chromosomal Integration of Latent State Human Herpes Virus 6 (HHV-6) by Kerri-Lynn Conrad
Infection Mechanism of Genus Ebolavirus by Keith Miller
Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients by Sally Wilson
The following projects were created in 2010 by members of the class BIOL 375 Virology.
Bluetongue Virus (BTV) by Kerri-Lynn Conrad
Fibropapilloma-Associated Turtle Herpesvirus by Keith Miller
Venezuelan equine encephalitis virus by Kelly Wahl
Cucurbit yellow stunting disorder virus (CYSDV) by Sally Wilson
The following projects were created in 2008 by members of the class BIOL 375 Virology.
Kashmir Bee Virus by Devon Fitzgerald
Mouse Mammary Tumor Virus by Piero Sanfilippo
Rinderpest by Trevor Brolin
Tospovirus by Sasha Minian